000 | 01215 a2200301 4500 | ||
---|---|---|---|
005 | 20250516090202.0 | ||
264 | 0 | _c20120710 | |
008 | 201207s 0 0 eng d | ||
022 | _a1524-4636 | ||
024 | 7 |
_a10.1161/ATVBAHA.112.245571 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFazio, Sergio | |
245 | 0 | 0 |
_aInhibition of apolipoprotein(a) synthesis by farnesoid X receptor and fibroblast growth factor 15/19: a step toward selective lipoprotein(a) therapeutics. _h[electronic resource] |
260 |
_bArteriosclerosis, thrombosis, and vascular biology _cMay 2012 |
||
300 |
_a1060-2 p. _bdigital |
||
500 | _aPublication Type: Editorial; Research Support, N.I.H., Extramural; Comment | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApolipoproteins A _xgenetics |
650 | 0 | 4 |
_aAtherosclerosis _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibroblast Growth Factors _xmetabolism |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
700 | 1 | _aLinton, MacRae F | |
773 | 0 |
_tArteriosclerosis, thrombosis, and vascular biology _gvol. 32 _gno. 5 _gp. 1060-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/ATVBAHA.112.245571 _zAvailable from publisher's website |
999 |
_c21716587 _d21716587 |